
CAMP4 Therapeutics Corporation
CAMPHealthcare|Biotechnology|US
$4.06
+0.34 (+9.14%)
Tangible Book / Share
$1.36
Cash / Share
$1.58
Ownership Breakdown
69.1%
Float
62.8M
Shares Outstanding
43.3M
Float Shares
Major Holders (40)
Combined: 235.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | IA, HC | 12.20% | 6,307,636 | Jan 8, 2026 | 13D/G |
| Coastlands Capital LLC | HC, OO | 9.99% | 4,886,722 | Dec 11, 2025 | 13D/G |
| Coastlands Capital GP LLC | Other | 9.99% | 4,886,722 | Dec 11, 2025 | 13D/G |
| Coastlands Capital Partners LP | Partnership | 9.99% | 4,886,722 | Dec 11, 2025 | 13D/G |
| Coastlands Capital LP | IA, PN | 9.99% | 4,886,722 | Dec 11, 2025 | 13D/G |
| Matthew D. Perry | HC, IN | 9.99% | 4,886,722 | Dec 11, 2025 | 13D/G |
| Andrew J. Schwab | Individual | 9.90% | 6,379,125 | Aug 31, 2026 | 13D/G |
| Kush Parmar | Individual | 9.90% | 6,370,125 | Aug 31, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 7.80% | 4,908,857 | Nov 5, 2026 | 13D/G |
| FMR LLC | Holding company | 7.80% | 4,908,857 | Nov 5, 2026 | 13D/G |
| Vivo Opportunity, LLC | Other | 7.40% | 3,856,991 | Feb 13, 2026 | 13D/G |
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 7.40% | 3,856,991 | Feb 13, 2026 | 13D/G |
| 5AM Ventures VII, L.P. | Partnership | 6.30% | 4,034,085 | Aug 31, 2026 | 13D/G |
| 5AM Partners VII, LLC | Other | 6.30% | 4,034,085 | Aug 31, 2026 | 13D/G |
| Amir Nashat | Individual | 6.30% | 3,932,251 | Aug 19, 2026 | 13D/G |
| Trails Edge Capital Partners, LP | IA, PN | 6.00% | 3,790,636 | Aug 10, 2026 | 13D/G |
| Ortav Yehudai | Individual | 6.00% | 3,790,636 | Aug 10, 2026 | 13D/G |
| Trails Edge Biotechnology Master Fund, LP | Partnership | 6.00% | 3,790,636 | Aug 10, 2026 | 13D/G |
| Bam GP LLC | HC, OO | 4.99% | 2,591,097 | Aug 14, 2026 | 13D/G |
| Dames GP LLC | HC, OO | 4.99% | 2,591,097 | Aug 14, 2026 | 13D/G |
| Dmitry Balyasny | HC, IN | 4.99% | 2,591,097 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management Holdings LP | HC, PN | 4.99% | 2,591,097 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management L.P. | IA, PN | 4.99% | 2,591,097 | Aug 14, 2026 | 13D/G |
| Polaris Management Co. VII, L.L.C. | Other | 4.80% | 3,023,161 | Aug 19, 2026 | 13D/G |
| Enavate Sciences GP, LLC | Other | 4.80% | 2,495,562 | Mar 11, 2026 | 13D/G |
| Everest Aggregator, LP | Partnership | 4.80% | 2,495,562 | Mar 11, 2026 | 13D/G |
| Michael P. Rubin | Individual | 4.80% | 2,238,244 | Nov 14, 2025 | 13D/G |
| Polaris Partners VII, L.P. | Partnership | 4.50% | 2,825,500 | Aug 19, 2026 | 13D/G |
| Marc L. Andreessen | Individual | 4.50% | 2,125,339 | Nov 14, 2025 | 13D/G |
| Benjamin A. Horowitz | Individual | 4.50% | 2,125,339 | Nov 14, 2025 | 13D/G |
| AH Bio Fund I, L.P. | Partnership | 3.40% | 1,579,885 | Nov 14, 2025 | 13D/G |
| AH Equity Partners Bio I, L.L.C. | Other | 3.40% | 1,579,885 | Nov 14, 2025 | 13D/G |
| 5AM Ventures VI, L.P. | Partnership | 3.20% | 2,033,270 | Aug 31, 2026 | 13D/G |
| 5AM Partners VI, LLC | Other | 3.20% | 2,033,270 | Aug 31, 2026 | 13D/G |
| Smrs-Tope LLC | Other | 2.70% | 1,271,948 | Oct 1, 2025 | 13D/G |
| HarbourVest Partners L.P. | Investment adviser | 2.70% | 1,271,948 | Oct 1, 2025 | 13D/G |
| HarbourVest Partners, LLC | Investment adviser | 2.70% | 1,271,948 | Oct 1, 2025 | 13D/G |
| Hvst-Tope LLC | Other | 2.70% | 1,271,948 | Oct 1, 2025 | 13D/G |
| Northpond Ventures II, LP | Partnership | 2.10% | 1,003,193 | Nov 14, 2025 | 13D/G |
| Northpond Ventures II GP, LLC | Other | 2.10% | 1,003,193 | Nov 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 17,289,708 acquired · 593,613 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Gold Kelly | Chief Financial Officer | Aug 31, 2026 | BUY | 10,000 | $3.96 | $39.6K | Form 4 |
| Schwab Andrew J. | director | Aug 27, 2026 | SELL | 400,000 | $4.04 | $1.6M | Form 4 |
| Schwab Andrew J. | director | Aug 24, 2026 | SELL | 10 | $4.50 | $45.00 | Form 4 |
| Schwab Andrew J. | director | Aug 19, 2026 | SELL | 45,147 | $4.76 | $214.9K | Form 4 |
| Schwab Andrew J. | director | Aug 20, 2026 | SELL | 114,700 | $4.54 | $520.7K | Form 4 |
| Schwab Andrew J. | director | Aug 21, 2026 | SELL | 32,018 | $4.50 | $144.1K | Form 4 |
| Tardiff Daniel | Chief Scientific Officer | Aug 19, 2026 | SELL | 1,738 | $4.76 | $8.3K | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Aug 3, 2026 | BUY | 3,179,558 | $0.00 | $317.96 | Form 4 |
| Schwab Andrew J. | director | Aug 3, 2026 | AWARD | 3,179,558 | $0.00 | $317.96 | Form 4 |
| Young Richard A | director | Aug 3, 2026 | BUY | 16,378 | $1.65 | $27.0K | Form 4 |
| Maricich Yuri | Chief Medical Officer | Aug 3, 2026 | BUY | 6,551 | $1.65 | $10.8K | Form 4 |
| Gold Kelly | Chief Financial Officer | Aug 3, 2026 | BUY | 6,551 | $1.65 | $10.8K | Form 4 |
| Mandel-Brehm Josh | director, officer: Chief Executive Officer | Aug 3, 2026 | BUY | 6,551 | $1.65 | $10.8K | Form 4 |
| WILLIAMS DOUGLAS E | director | Jun 10, 2026 | AWARD | 28,000 | $4.34 | $121.5K | Form 4 |
| Young Richard A | director | Jun 10, 2026 | AWARD | 28,000 | $4.34 | $121.5K | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Jun 10, 2026 | AWARD | 28,000 | $4.34 | $121.5K | Form 4 |
| Holtzman Steven H | director | Jun 10, 2026 | AWARD | 28,000 | $4.34 | $121.5K | Form 4 |
| Stewart Murray | director | Jun 10, 2026 | AWARD | 28,000 | $4.34 | $121.5K | Form 4 |
| Nashat Amir | director, 10 percent owner: | Jun 10, 2026 | AWARD | 28,000 | $4.34 | $121.5K | Form 4 |
| Tardiff Daniel | Chief Scientific Officer | Apr 1, 2026 | AWARD | 170,000 | $4.46 | $758.2K | Form 4 |
| Maricich Yuri | Chief Medical Officer | Apr 1, 2026 | AWARD | 215,000 | $4.46 | $958.9K | Form 4 |
| Gold Kelly | Chief Financial Officer | Apr 1, 2026 | AWARD | 215,000 | $4.46 | $958.9K | Form 4 |
| Mandel-Brehm Josh | director, officer: Chief Executive Officer | Apr 1, 2026 | AWARD | 580,000 | $4.46 | $2.6M | Form 4 |
| MacLean Michael F | director | Apr 1, 2026 | AWARD | 56,000 | $4.46 | $249.8K | Form 4 |
| MacLean Michael F | director: | Apr 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Tardiff Daniel | Chief Scientific Officer | Dec 11, 2025 | AWARD | 145,500 | $6.01 | $874.5K | Form 4 |
| Maricich Yuri | Chief Medical Officer | Dec 11, 2025 | AWARD | 190,000 | $6.01 | $1.1M | Form 4 |
| Gold Kelly | Chief Financial Officer | Dec 11, 2025 | AWARD | 190,000 | $6.01 | $1.1M | Form 4 |
| Mandel-Brehm Josh | director, officer: Chief Executive Officer | Dec 11, 2025 | AWARD | 425,000 | $6.01 | $2.6M | Form 4 |
| Tardiff Daniel | Chief Scientific Officer | Oct 1, 2025 | OTHER | 5,000 | $3.53 | $17.6K | Form 4 |
| Tardiff Daniel | Chief Scientific Officer | Oct 1, 2025 | OTHER | 25,000 | $3.86 | $96.5K | Form 4 |
| Tardiff Daniel | Chief Scientific Officer | Oct 1, 2025 | OTHER | 22,289 | $9.08 | $202.4K | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Sep 11, 2025 | AWARD | 2,941,176 | $1.53 | $4.5M | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Sep 11, 2025 | BUY | 2,941,176 | $1.53 | $4.5M | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Sep 11, 2025 | BUY | 1,221,721 | $1.53 | $1.9M | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Sep 11, 2025 | BUY | 85,468 | $1.53 | $130.8K | Form 4 |
| Nashat Amir | director, 10 percent owner: | Sep 11, 2025 | BUY | 1,221,721 | $1.53 | $1.9M | Form 4 |
| Nashat Amir | director, 10 percent owner: | Sep 11, 2025 | BUY | 85,468 | $1.53 | $130.8K | Form 4 |
| Maricich Yuri | Chief Medical Officer | Sep 11, 2025 | BUY | 6,060 | $1.65 | $10.0K | Form 4 |
| Gold Kelly | Chief Financial Officer | Sep 11, 2025 | BUY | 6,060 | $1.65 | $10.0K | Form 4 |
| Mandel-Brehm Josh | director, officer: Chief Executive Officer | Sep 11, 2025 | BUY | 6,060 | $1.65 | $10.0K | Form 4 |
| Young Richard A | director | Sep 11, 2025 | BUY | 15,151 | $1.65 | $25.0K | Form 4 |
| Boylan James P | director | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Young Richard A | director | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Higgins Michael J | director | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Holtzman Steven H | director | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Nashat Amir | director, 10 percent owner: | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Thadhani Ravi I. | director | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| Ragan Paula | director | Jun 25, 2025 | AWARD | 9,000 | $1.56 | $14.0K | Form 4 |
| WILLIAMS DOUGLAS E | director | Mar 17, 2025 | OTHER | 0 | — | — | Form 4 |
| Bumcrot David | Chief Scientific Officer | Apr 1, 2025 | AWARD | 45,000 | $3.86 | $173.7K | Form 4 |
| Maricich Yuri | Chief Medical Officer | Apr 1, 2025 | AWARD | 80,000 | $3.86 | $308.8K | Form 4 |
| Gold Kelly | Chief Financial Officer | Apr 1, 2025 | AWARD | 80,000 | $3.86 | $308.8K | Form 4 |
| Mandel-Brehm Josh | director, officer: Chief Executive Officer | Apr 1, 2025 | AWARD | 160,000 | $3.86 | $617.6K | Form 4 |
| WILLIAMS DOUGLAS E | director | Mar 17, 2025 | AWARD | 17,787 | $5.37 | $95.5K | Form 4 |
| Stewart Murray | director | Mar 17, 2025 | AWARD | 17,787 | $5.37 | $95.5K | Form 4 |
| WILLIAMS DOUGLAS E | director: | Mar 17, 2025 | OTHER | 0 | — | — | Form 4 |
| Stewart Murray | director: | Mar 17, 2025 | OTHER | 0 | — | — | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 353,718 | — | — | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 1,250,061 | — | — | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | BUY | 909,090 | $11.00 | $10.0M | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 24,745 | — | — | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 87,448 | — | — | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 980,829 | — | — | Form 4 |
| Polaris Management Co. VII, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 277,536 | — | — | Form 4 |
| Polaris Partners GP X, L.L.C. | 10 percent owner | Oct 15, 2024 | OTHER | 0 | — | — | Form 4 |
| Northpond Ventures II GP, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 1,003,193 | — | — | Form 4 |
| Northpond Ventures II GP, LLC | 10 percent owner | Oct 15, 2024 | BUY | 763,636 | $11.00 | $8.4M | Form 4 |
| Northpond Ventures II GP, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 471,415 | — | — | Form 4 |
| Northpond Ventures II GP, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 11,251,624 | — | — | Form 4 |
| Northpond Ventures II GP, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 5,287,303 | — | — | Form 4 |
| AH Equity Partners Bio I, L.L.C. | 10 percent owner | Oct 15, 2024 | BUY | 181,818 | $11.00 | $2.0M | Form 4 |
| AH Equity Partners Bio I, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 1,398,067 | — | — | Form 4 |
| AH Equity Partners Bio I, L.L.C. | 10 percent owner | Oct 15, 2024 | BUY | 545,454 | $11.00 | $6.0M | Form 4 |
| AH Equity Partners Bio I, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 679,163 | — | — | Form 4 |
| AH Equity Partners Bio I, L.L.C. | 10 percent owner | Oct 15, 2024 | CONVERSION | 15,001,312 | — | — | Form 4 |
| Enavate Sciences GP, LLC | 10 percent owner | Oct 15, 2024 | BUY | 1,363,636 | $11.00 | $15.0M | Form 4 |
| Enavate Sciences GP, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 2,422,166 | — | — | Form 4 |
| Enavate Sciences GP, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 27,166,530 | — | — | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Oct 15, 2024 | BUY | 909,090 | $11.00 | $10.0M | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 1,716,055 | — | — | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 302,770 | — | — | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 15,002,166 | — | — | Form 4 |
| 5AM Partners VI, LLC | 10 percent owner | Oct 15, 2024 | CONVERSION | 3,395,816 | — | — | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 353,718 | — | — | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 1,250,061 | — | — | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | BUY | 909,090 | $11.00 | $10.0M | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 24,745 | — | — | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 87,448 | — | — | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 980,829 | — | — | Form 4 |
| Nashat Amir | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 277,536 | — | — | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Oct 15, 2024 | BUY | 909,090 | $11.00 | $10.0M | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 378,463 | — | — | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 1,337,592 | — | — | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 302,770 | — | — | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 15,002,166 | — | — | Form 4 |
| Schwab Andrew J. | director, 10 percent owner: | Oct 15, 2024 | CONVERSION | 3,395,816 | — | — | Form 4 |
| Holtzman Steven H | director | Oct 15, 2024 | CONVERSION | 8,917 | — | — | Form 4 |
| Holtzman Steven H | director | Oct 15, 2024 | CONVERSION | 100,014 | — | — | Form 4 |